Pharmacy and Pharmaceutical Sciences > News > Faculty & Student Scholarship > June 2025 Updates

June 2025 Updates

The Faculty and Student Scholarship section is provided as a service to the WSU College of Pharmacy and Pharmaceutical Sciences community for sharing publications, presentations, and other highly transactional types of information. Accuracy of the information presented is the responsibility of those who submitted it. Submissions are reviewed for compliance with state statutes and ethics guidelines but are not edited for spelling, grammar, or clarity. Submission for Pharmaceutical Sciences faculty and PhD students can be directed to Kami Ryplewski and submissions for Pharmacotherapy faculty and Doctor of Pharmacy students to Faith Townsend.

Faculty Scholarship

Publications

  • Dana Bowers published a book chapter titled “Pseudomonas aeruginosa” in the American College of Clinical Pharmacology Infectious Diseases Self-Assessment Program (IDSAP).
  • Baker DE,Levien TL. Drug Evaluation – Vanzacaftor/tezacaftor/deutivacaftor (Alyftrek), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Wolters Kluwer Health, April 2025.
  • Levien TL, Baker DE. Drug Evaluation – Concizumab (Alhemo), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Wolters Kluwer Health, April 2025.
  • Johnson TJ, Hitt EM, Levien TL, Baker DE. Levien TL. Drug Evaluation – Crinecerfont (Crenessity), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Wolters Kluwer Health, April 2025.
  • Baker DE, Levien TL. Drug Evaluation – Landiolol (Rapidlyk), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Wolters Kluwer Health, April 2025.
  • Baker DE. Drug Utilization Evaluation – Landiolol (Rapidlyk), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Clinical Drug Information, LLC, April 2025.
  • Baker DE, Levien TL. Drug Evaluation – Cosibelimab (Unloxcyt), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Wolters Kluwer Health, May 2025.
  • Baker DE, Levien TL. Drug Evaluation – Zenocutuzumab (Bizengri), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Wolters Kluwer Health, May 2025.
  • Levien TL, Baker DE. Drug Evaluation – Datopotamab deruxtecan-dlnk (Datroway), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Wolters Kluwer Health, May 2025.
  • Hitt EM, Levien TL, Baker DE. Drug Evaluation – Treosulfan (Grafapex), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Wolters Kluwer Health, May 2025.
  • Kleven H, Moffat T, Levien TL, Baker DE. Drug Evaluation – Suzetrigine (Journavx), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Wolters Kluwer Health, May 2025.
  • Baker DE, Levien TL. Drug Utilization Evaluation – Suzetrigine (Journavx), In: Hayes B, Baker DE, Levien TL (Ed.) The Formulary Monograph Service (TM), St. Louis, MO: Clinical Drug Information, LLC, May 2025
  • Maxson R, Neumiller JJ, Aistrope D, Weltman MR, Chow S. Cardiovascular-kidney-metabolic syndrome medications: A time to rebrand? Am J Health Syst Pharm 2025 Apr 2 [Online ahead of print].
  • Alicic RZ, Duru OK, Jones CR, Kornowske LM, Daratha KB, Reynolds CL, Pavkov ME, Koyama AK, Xu F, Nicholas SB, Neumiller JJ, Norris KC, Hennessey KA, Tuttle KR. Incidence of chronic kidney disease among adults with prediabetes in the CURE-CKD registry, 20013-2020. Diabetes Obes Metab 2025 Apr 2 [Online ahead of print].
  • Barber T, Neumiller JJ, Fravel MA, Page RL 2nd, Tuttle KR. Using guideline-directed medical therapies to improve kidney and cardiovascular outcomes in patients with chronic kidney disease. Am J Health Syst Pharm 2025 Apr 8:zxaf045 [Online ahead of print]
  • Tuttle KR, Kornowske LM, Jones CR, Daratha KB, Alicic RZ, Reynolds CL, Neumiller JJ, Bensink ME, Gong W, Norris KC, Nicholas SB; CURE-CKD Consortium. Population-level risk factors for kidney outcomes in IgA Nephropathy: The CURE-CKD Registry. Kidney Med 2025 Feb 13;7(4):100981.

Presentations

  • Joshua Neumiller and other speakers summarized concepts from the February 2025 publication of the Geriatric Diabetes Society’s consensus statement, “Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies,” in a session held during the Advanced Technologies & Treatments for Diabetes (ATTD) 2025 in Amsterdam.

Service

  • Josh Neumiller, Mary Paine, and Danial Baker were delegates at the USP Convention Meeting 2025 in Bethesda, MD on May 6-8, 2025.

Grants

  • Jason Brouillard received a WSU Smith Teaching and Learning Grant for $5,000 last month. Jason Brouillard, Kim McKeirnan, Jennifer Robinson, and Megan Willson will be utilizing these grant funds to perform some research related to the Mental Health First Aid training.

Awards

  • Dana Bowers was notified that she is a Top 5 Peer Reviewer for the American Journal of Pharmaceutical Education. She will receive recognition at the American Association of Colleges of Pharmacy annual meeting, Pharmacy Education, in July 2025 in Chicago, IL.  

Other Faculty Achievements

  • Dana Bowers received a Bachelor of Arts Degree in English, Rhetoric and Professional Writing with a certificate in Editing and Publishing through WSU Global Campus.

Student Achievement        

Pharmaceutical Sciences and Molecular Medicine students

  • Jessie Hao (graduate student, Paine lab)was selected to give a talk at the 2025 Drug Metabolism Gordon Research Seminar in July for her research related to the botanical product kratom. The meeting will be held in Holderness, NH, and the title of her talk is “The psychotropic botanical kratom induces cytochrome P450 enzymes in human hepatocytes”.

Successfully Passed Final Defense:

  • Dr. Anoud Ailabouni, April 1, 2025
  • Dr. Namrata Bachhav, May 5, 2025

Successfully Passed Preliminary Exam:

  • Jiawei Liu, April 30, 2025

Doctor of Pharmacy students